Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
BiondVax Pharmaceuticals Ltd ADR is a biotechnology business based in the US. BiondVax Pharmaceuticals Ltd ADR shares (BVXV) are listed on the NASDAQ and all prices are listed in US Dollars. BiondVax Pharmaceuticals Ltd ADR employs 15 staff and has a market cap (total outstanding shares value) of 0.00.
Finder Award
SoFi Invest
Finder Award
eToro
Robinhood
| Latest market close | $2.56 |
|---|---|
| 52-week range | $2.37 - $22.90 |
| 50-day moving average | $5.47 |
| 200-day moving average | $9.66 |
| Wall St. target price | $57.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.30 |
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $2.56 from 2023-02-02
| 1 week (2023-01-27) | -1.92% |
|---|---|
| 1 month (2023-01-04) | -14.09% |
| 3 months (2022-11-04) | 204.76% |
| 6 months (2022-08-04) | 113.33% |
| 1 year (2022-02-04) | 91.04% |
|---|---|
| 2 years (2021-02-04) | -45.30% |
| 3 years (2020-02-04) | 10.08 |
| 5 years (2018-02-02) | 6.7899 |
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -20.98% |
| Return on equity TTM | -432.25% |
| Profit margin | 0% |
| Book value | $0.61 |
| Market capitalisation | $4.9 million |
TTM: trailing 12 months
We're not expecting BiondVax Pharmaceuticals Ltd ADR to pay a dividend over the next 12 months.
BiondVax Pharmaceuticals Ltd ADR's shares were split on a 1:10 basis on 25 November 2022. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your BiondVax Pharmaceuticals Ltd ADR shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for BiondVax Pharmaceuticals Ltd ADR shares which in turn could have impacted BiondVax Pharmaceuticals Ltd ADR's share price.
Over the last 12 months, BiondVax Pharmaceuticals Ltd ADR's shares have ranged in value from as little as $2.37 up to $22.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while BiondVax Pharmaceuticals Ltd ADR's is 2.5842. This would suggest that BiondVax Pharmaceuticals Ltd ADR's shares are significantly more volatile than the average for this exchange and represent a higher risk.
BiondVax Pharmaceuticals Ltd. , a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious diseases and other illnesses in Israel. The company has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was incorporated in 2003 and is headquartered in Jerusalem, Israel. .
Everything we know about the Neuraxis IPO, plus information on how to buy in.
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.